Smallpox - simply hearing the word evokes images of countless people suffering gruesome deaths throughout recorded history. Known scientifically as variola, the virus had 30 percent mortality rate and survivors were branded with pox scars for life. For millennia, physicians often did more harm t... Read More
This episode: Kate Franz and Matt Woodruff from Audiommunity join me to talk about a clinical trial of peanut immunotherapy with probiotics to treat peanut allergies!
(29 MB, 31.75 minutes)
A group of collaborators led by the University of Southampton have been awarded a British Council Newton Fund Institutional Links Grant to support ground-breaking research towards reducing the burden of infectious disease in Malaysia. Read More
BOC Sciencs-Scientists found that a common food additive diacetyl can bring great damage to lungs when it be inhaled. And workers who roast coffee beans and make popcorn have frequent contact with the substance, that's one of the main reason that workers at these post will contract serious lung ... Read More
Researchers from the University of Zurich and the University Hospital Zurich reveal possible new treatment methods for a rare, usually fatal brain disease. Thanks to their discovery that specific antibodies play a key role in combating the viral infection, a vaccine against the disease "progress... Read More
A new drug acts as a roadblock for malaria, curing mice of established infection, according to a study in The Journal of Experimental Medicine. Treatment was not associated with obvious side effects, suggesting that the drug may also be safe and effective in humans. Read More
Dr. Sally Hodder, Director of the West Virginia Clinical and Translational Science Institute, will share the results from WAVES, the First International Phase 3 HIV Study to Enroll Only Women. Women are routinely underrepresented in HIV clinical trials although they account for half of the globa... Read More
Ron Dagan, Professor of Pediatrics and Infectious Diseases at the Pediatric Infectious Disease Unit, Soroka University Medical Center, Israel will discuss his research that showed how the introduction of both pneumococcal conjugate vaccines (PCVs) and rotavirus vaccines (RVs) led to the rapid an... Read More
The individuals who believe that certain types of gain-of-function experiments should not be done because they are too dangerous (including Lipsitch, Osterholm, Wain-Hobson,) cite the 1977 influenza virus H1N1 strain as an example of a laboratory accident that has led to a global epidemic. A new... Read More
ANN ARBOR, Mich. -- With every breath you take, microbes have a chance of making it into your lungs. But what happens when they get there? And why do dangerous lung infections like pneumonia happen in some people, but not others? Read More
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS. Read More
Some holiday fun from last winter composed of different collected plate contaminants. Based on colony morphology and wet mounts, these bacteria are likely to be: Staphylococcus sp. (white), Serratia marcescens (dark orange), and Micrococcus luteus (creamy yellow). The design was incubated for 5-... Read More
Acid Fast stain done on a mix of Staphylococcus aureus and Mycobacterium smegmatis. The stain was done on a culture of M. smegmatis that was incubated on a TSA slant with 1ml TSB added at 37 degree's C for 4 days, S. aureus was incubated in TSB at 37 degree's C for 24 hrs. Several loops of eac... Read More
A Canadian research team at the IRCM in Montreal, led by molecular virologist Eric A. Cohen, PhD, made a significant discovery on how HIV escapes the body's antiviral responses. The team uncovered how an HIV viral protein known as Vpu tricks the immune system by using its own regulatory process ... Read More
Scientists have discovered new ways in which the malaria parasite survives in the blood stream of its victims, a discovery that could pave the way to new treatments for the disease.
The researchers at the Medical Research Council's (MRC) Toxicology Unit based at the University of Leicester an... Read More
A vaccine that protects against a wide variety of influenza viruses (a so-called universal flu vaccine) is a critical public health goal given the significant rates of illness and death caused by seasonal influenza and the potentially devastating effects of a pandemic influenza strain. Now, rese... Read More
This episode: When digesting wood, shipworms outsource their microbial symbionts from gut to gills!
(9.7 MB, 10.6 minutes)
National Institutes of Health (NIH) scientists report that a single dose of an experimental Ebola virus (EBOV) vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if giv... Read More
Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they have struggled to find ways to grow it in human cells in the lab -- an essential part of learning how the virus works and developing new effective tr... Read More